High‐Content Screening of Synaptic Density Modulators in Primary Neuronal Cultures
Audrey Coulon(Inserm), Julien Chapuis(Inserm), Jean‐Charles Lambert(Inserm), Julie Dumont(Inserm), Dolores Siedlecki‐Wullich(Inserm), Erwan Lambert(Inserm), Priscille Brodin(Centre National de la Recherche Scientifique), Devrim Kilinc(Inserm), Tiago Mendes(Inserm), Alexandre Vandeputte(Centre National de la Recherche Scientifique), Chloé Najdek(Inserm), Anne‐Marie Ayral(Inserm), Carla Gelle(Inserm), Florie Demiautte(Inserm)
Cited by 3
Related Papers
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
|Molecular Psychiatry|2013|440
Neuroinflammation in Alzheimer disease
|Nature reviews. Immunology|2024|401
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
|Molecular Psychiatry|2009|203
The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
|Acta Neuropathologica|2019|170